This company appears to have been delisted
Reason: Merged with Alumis
Last recorded trade on: June 19, 2025
Source: https://investors.alumis.com/news-releases/news-release-details/alumis-completes-merger-acelyrin

ACELYRIN

SLRN

#8375

Rank

A$0.33 B

Marketcap

🇺🇸 United States

Country

A$3.30

Share price

0.00%

Change (1 day)

-47.99%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for ACELYRIN CIK: 0001962918

10-Q Quarterly Report FY2025 Q1

Language: English

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)

10-Q Quarterly Report FY2023 Q3

Language: English

Quarterly Reports (10-Q)

10-Q Quarterly Report FY2023 Q2

Language: English

Quarterly Reports (10-Q)

10-Q Quarterly Report FY2023 Q1

Language: English

Quarterly Reports (10-Q)

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions